Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

This year marks the 200th anniversary of the publication of the first codified description of the condition that we now know as Parkinson's disease.

Associate Professor Chrystalina Antoniades from the Nuffield Department of Clinical Neurosicences, and Dr Patrick Lewis from the University of Reading have co-organised the following events to mark the anniversary, together with the Oxford branch of Parkinson's UK.

Exhibition, 11-19 September

The author of the publication describing the condition, James Parkinson, called the disease the Shaking Palsy. Parkinson's talents, however, stretched well beyond neurology. He was a political agitator, general science writer and an influential geologist - all aspects of his work that are showcased in an exhibition from the collections of the Bodleian Library.

Conference, 18 September

This conference for people with Parkinson's, families, friends and healthcare professionals is devised and presented by Parkinson's UK Oxford Branch in collaboration with the University of Oxford's Nuffield Department of Clinical Neurosciences and other leading organisations.

Sessions cover:

  • Progress in research and therapy
  • Sharing best practice
  • Achieving best quality of life

Read more about the conference.

Similar stories

European Platform for Neurodegenerative Diseases launches repository of cohorts for researchers

The new Cohort Catalogue will facilitate discovery of over 60 neurodegeneration research cohorts from 17 countries across Europe

Ashmolean turns red for World Encephalitis Day

Our researchers are tackling the devastating brain condition encephalitis.

Bioelectronic implant offers an intelligent therapy to treat incontinence

The first participants in a clinical trial of a bioelectrical therapy to treat incontinence have received their 'smart' bioelectronic implants.

Direct evidence of reduced NMDA receptors in people with form of encephalitis

NMDAR-antibody encephalitis is an autoimmune brain condition caused by patient’s own antibodies that bind to NMDA (N-Methyl-D-Aspartate) receptors in the synapses between nerve cells.

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.